Neurodegenerative Disease & Obesity

Neurodegenerative disorders and obesity appear to have common pathologies including neuroinflammation. Targeting common pathways may prove to be a useful treatment strategy for neurodegenerative disease. Discover the latest research on neurodegenerative disorders and obesity here.

January 20, 2021
Open Access

Overweight/obesity in young adulthood interacts with aspects of EBV infection in MS etiology.

Neurology. Neuroimmunology and Neuroinflammation
Anna Karin HedströmLars Alfredsson
January 5, 2021

Small Molecule Inhibitors Targeting Biosynthesis of Ceramide, the Central Hub of the Sphingolipid Network

Journal of Medicinal Chemistry
Jan SkácelTakashi Tsukamoto
December 31, 2020
Open Access

Neuroprotective Effects of Coffee Bioactive Compounds: A Review

International Journal of Molecular Sciences
Katarzyna SocałaPiotr Wlaź
January 17, 2021

Agomelatine effects on fat-enriched diet induced neuroinflammation and depression-like behavior in rats.

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Redouane RebaiAbdennacer Boudah
January 6, 2021

Dysbiosis and Alzheimer's Disease: Cause or Treatment Opportunity?

Cellular and Molecular Neurobiology
Manuel H JaneiroMaite Solas
December 29, 2020

Association between facet joint orientation/tropism and lumbar intervertebral disc degeneration

British Journal of Neurosurgery
Murat Şakir EkşiM Necmettin Pamir
January 4, 2021

Lipoxygenase (LOX) Pathway: A Promising Target to Combat Cancer

Current Pharmaceutical Design
Vishnupriya P Vijaya Padma V
January 14, 2021
Comment / Editorial
Open Access

Obesity's role in MS: An intervention target with possible interactions.

Neurology. Neuroimmunology and Neuroinflammation
Kathryn C Fitzgerald, Ellen M Mowry
January 21, 2021
Open Access

Beneficial Effects of Epigallocatechin-3-O-Gallate, Chlorogenic Acid, Resveratrol, and Curcumin on Neurodegenerative Diseases.

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Ryuuta FukutomiMamoru Isemura
January 9, 2021
Open Access

Role of Sirtuins in Modulating Neurodegeneration of the Enteric Nervous System and Central Nervous System

Frontiers in Neuroscience
Pavithra ChandramowlishwaranShanthi Srinivasan
January 3, 2021

Plant miR171 modulates mTOR pathway in HEK293 cells by targeting GNA12

Molecular Biology Reports
Angelo GismondiAntonella Canini
January 23, 2021

Global pandemics interconnected - obesity, impaired metabolic health and COVID-19.

Nature Reviews. Endocrinology
Norbert StefanMatthias B Schulze
January 24, 2021
Open Access

Protective effect of grape seed extract and orlistat co-treatment against stroke: Effect on oxidative stress and energy failure.

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Safwen KadriMeherzia Mokni
January 25, 2021

Hydrogen as a Potential Therapeutic in Obesity: Targeting the Brain.

Trends in Endocrinology and Metabolism : TEM
Sergej M Ostojic
January 1, 2021
Open Access

From Obesity to Hippocampal Neurodegeneration: Pathogenesis and Non-Pharmacological Interventions

International Journal of Molecular Sciences
Thomas Ho-Yin Lee, Suk-Yu Yau
January 6, 2021

Nicotinamide as a Foundation for Treating Neurodegenerative Disease and Metabolic Disorders

Current Neurovascular Research
Kenneth Maiese
January 9, 2021
Open Access

AgRP neurons trigger long-term potentiation and facilitate food seeking.

Translational Psychiatry
Chunmei WangYong Xu

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved